Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Medicover AB ( ($SE:MCOV.B) ) is now available.
Medicover reported strong financial performance in the second quarter of 2025, with a 17.1% increase in revenue to €596.7 million and a 96.5% rise in operating profit to €41.7 million. The company achieved significant margin expansion across all profit measures, driven by robust organic growth and efficiency improvements, particularly in Poland and Romania. The acquisition of CityFit and the integration of Synlab businesses further bolstered results, while the healthcare services and diagnostic services divisions both showed impressive growth.
More about Medicover AB
Medicover is a leading international healthcare and diagnostic services company founded in 1995. It operates a wide range of ambulatory clinics, hospitals, specialty-care facilities, laboratories, and blood-drawing points, with major markets in Poland, Germany, Romania, and India.
Average Trading Volume: 102,890
Technical Sentiment Signal: Buy
Current Market Cap: SEK38.58B
Find detailed analytics on MCOV.B stock on TipRanks’ Stock Analysis page.